Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12

FASEB Journal

Volumn 23, Issue 11, 2009, Pages 3906-3916

  O'Boyle, Graeme ^a   Mellor, Paul ^a   Kirby, John A ^a   Ali, Simi ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Chemokine; G protein coupled receptors; Glycosaminoglycan; Integrin adhesion; Receptor desensitization

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HEPARAN SULFATE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; STROMAL CELL DERIVED FACTOR 1; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

MURINAE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CXCL12; CHEMOTAXIS, LEUKOCYTE; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIUM; FEMALE; HEPARITIN SULFATE; HUMANS; INJECTIONS, INTRAVENOUS; INTEGRIN ALPHA4BETA1; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 70350528813     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-134643     Document Type: Article

References (42)

1. Proudfoot, A. E. (2006) The biological relevance of chemokine- proteoglycan interactions. Biochem. Soc. Trans. 34, 422-426
2. Johnson, Z., Kosco-Vilbois, M. H., Herren, S., Cirillo, R., Muzio, V., Zaratin, P., Carbonatto, M., Mack, M., Smailbegovic, A., Rose, M., Lever, R., Page, C., Wells, T. N., and Proudfoot, A. E. (2004) Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173, 5776-5785 (Pubitemid 39392167)
3. Ali, S., Fritchley, S. J., Chaffey, B. T., and Kirby, J. A. (2002) Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology 12, 535-543
4. Ali, S., Robertson, H., Wain, J. H., Isaacs, J. D., Malik, G., and Kirby, J. A. (2005) A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J. Immunol. 175, 1257-1266 (Pubitemid 41095015)
5. Ali, S., O'Boyle, G., Mellor, P., and Kirby, J. A. (2007) An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Mol. Immunol. 44, 1477-1482 (Pubitemid 44792739)
6. Proudfoot, A. E., Handel, T. M., Johnson, Z., Lau, E. K., LiWang, P., Clark-Lewis, I., Borlat, F., Wells, T. N., and Kosco-Vilbois, M. H. (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100, 1885-1890 (Pubitemid 36254543)
7. Johnson, Z., Power, C. A., Weiss, C., Rintelen, F., Ji, H., Ruckle, T., Camps, M., Wells, T. N., Schwarz, M. K., Proudfoot, A. E., and Rommel, C. (2004) Chemokine inhibition-why, when, where, which and how? Biochem. Soc. Trans. 32, 366-377 (Pubitemid 38582130)
8. Fricker, S. P. (2008) A novel CXCR4 antagonist for hematopoietic stem cell mobilization. Expert Opin. Investig. Drugs 17, 1749-1760
9. Bursill, C. A., McNeill, E., Wang, L., Hibbitt, O. C., Wade-Martins, R., Paterson, D. J., Greaves, D. R., and Channon, K. M. (2009) Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition. Gene Ther. 16, 93-102
10. Potzinger, H., Geretti, E., Brandner, B., Wabitsch, V., Piccinini, A. M., Rek, A., and Kungl, A. J. (2006) Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs. Biochem. Soc. Trans. 34, 435-437 (Pubitemid 43954005)
11. Proudfoot, A. E. (2008) Is CCR2 the right chemokine receptor to target in rheumatoid arthritis? Arthritis Rheum. 58, 1889-1891
12. Comerford, I., and Nibbs, R. J. (2005) Post-translational control of chemokines: a role for decoy receptors? Immunol. Lett. 96, 163-174 (Pubitemid 39600772)
13. Van Coillie, E., Van Damme, J., and Opdenakker, G. (1999) The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 10, 61-86
14. Culley, F. J., Fadlon, E. J., Kirchem, A., Williams, T. J., Jose, P. J., and Pease, J. E. (2003) Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur. J. Immunol. 33, 1302-1310 (Pubitemid 36609148)
15. Rueda, P., Balabanian, K., Lagane, B., Staropoli, I., Chow, K., Levoye, A., Laguri, C., Sadir, R., Delaunay, T., Izquierdo, E., Pablos, J. L., Lendinez, E., Caruz, A., Franco, D., Baleux, F., Lortat-Jacob, H., and Arenzana-Seisdedos, F. (2008) The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS ONE 3, e2543
16. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56 (Pubitemid 32225831)
17. Dowsland, M. H., Harvey, J. R., Lennard, T. W., Kirby, J. A., and Ali, S. (2003) Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments? Curr. Med. Chem. 10, 579-592
18. Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A., Thelen, M., Montes, M., Virelizier, J. L., Delepierre, M., Baleux, F., Lortat-Jacob, H., and Arenzana-Seisdedos, F. (1999) Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 274, 23916-23925 (Pubitemid 129531503)
19. Harvey, J. R., Mellor, P., Eldaly, H., Lennard, T. W., Kirby, J. A., and Ali, S. (2007) Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids? Clin. Cancer Res. 13, 1562-1570 (Pubitemid 46450448)
20. O'Boyle, G., Brain, J. G., Kirby, J. A., and Ali, S. (2007) Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2. Mol. Immunol. 44, 1944-1953 (Pubitemid 44827260)
21. Edgell, C. J., McDonald, C. C., and Graham, J. B. (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U. S. A. 80, 3734-3737
22. Hardy, L. A., Booth, T. A., Lau, E. K., Handel, T. M., Ali, S., and Kirby, J. A. (2004) Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration. Lab. Invest. 84, 81-90 (Pubitemid 41656437)
23. Konstandin, M. H., Sester, U., Klemke, M., Weschenfelder, T., Wabnitz, G. H., and Samstag, Y. (2006) A novel flow-cytometry-based assay for quantification of affinity and avidity changes of integrins. J. Immunol. Meth. 310, 67-77 (Pubitemid 43375977)
24. Iwamoto, T., Okamoto, H., Toyama, Y., and Momohara, S. (2008) Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 275, 4448-4455
25. Colville-Nash, P., and Lawrence, T. (2003) Air-pouch models of inflammation and modifications for the study of granuloma-mediated cartilage degradation. Meth. Mol. Biol. 225, 181-189
26. Al-Hamidi, A., Pekalski, M., Robertson, H., Ali, S., and Kirby, J. A. (2008) Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells. Mol. Immunol. 45, 4000-4007
27. Laguri, C., Arenzana-Seisdedos, F., and Lortat-Jacob, H. (2008) Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. Carbohydr. Res. 343, 2018-2023
28. Al-Mughales, J., Blyth, T. H., Hunter, J. A., and Wilkinson, P. C. (1996) The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines. Clin. Exp. Immunol. 106, 230-236 (Pubitemid 26359887)
29. Hecht, I., Cahalon, L., Hershkoviz, R., Lahat, A., Franitza, S., and Lider, O. (2003) Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Internat. Immunol. 15, 29-38 (Pubitemid 36163766)
30. Gouwy, M., Struyf, S., Noppen, S., Schutyser, E., Springael, J. Y., Parmentier, M., Proost, P., and Van Damme, J. (2008) Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol. Pharmacol. 74, 485-495
31. Marinissen, M. J., and Gutkind, J. S. (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharm. Sci. 22, 368-376 (Pubitemid 32592476)
32. O'Boyle, G., Brain, J. G., Kirby, J. A., and Ali, S. (2007) Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2. Mol. Immunol. 44, 1954-1963 (Pubitemid 44827260)
33. Sin, Y. M., Sedgwick, A. D., Chea, E. P., and Willoughby, D. A. (1986) Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse. Ann. Rheum. Dis. 45, 873-877
34. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., and Springer, T. A. (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101-1109
35. Misra, P., Lebeche, D., Ly, H., Schwarzkopf, M., Diaz, G., Hajjar, R. J., Schecter, A. D., and Frangioni, J. V. (2008) Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J. Nucl. Med. 49, 963-969 (Pubitemid 351793437)
36. Sweeney, E. A., Lortat-Jacob, H., Priestley, G. V., Nakamoto, B., and Papayannopoulou, T. (2002) Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 99, 44-51
37. Lenoir, M., Djerdjouri, B., and Perianin, A. (2004) Stroma cell-derived factor 1alpha mediates desensitization of human neutrophil respiratory burst in synovial fluid from rheumatoid arthritic patients. J. Immunol. 172, 7136-7143 (Pubitemid 38669157)
38. Glynn, P. C., Henney, E. M., and Hall, I. P. (2001) Peripheral blood neutrophils are hyperresponsive to IL-8 and Gro-alpha in cryptogenic fibrosing alveolitis. Eur. Respir. J. 18, 522-529
39. Signoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P. J., Tran, T., Brass, L. F., Rosenkilde, M. M., Schwartz, T. W., Holmes, W., Dallas, W., Luther, M. A., Wells, T. N., Hoxie, J. A., and Marsh, M. (1997) Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell. Biol. 139, 651-664 (Pubitemid 27485831)
40. Venkatesan, S., Rose, J. J., Lodge, R., Murphy, P. M., and Foley, J. F. (2003) Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. Mol. Biol. Cell 14, 3305-3324 (Pubitemid 37013129)
41. Chigaev, A., Waller, A., Zwartz, G. J., Buranda, T., and Sklar, L. A. (2007) Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin. J. Immunol. 178, 6828-6839
42. Shen, H., Cheng, T., Olszak, I., Garcia-Zepeda, E., Lu, Z., Herrmann, S., Fallon, R., Luster, A. D., and Scadden, D. T. (2001) CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J. Immunol. 166, 5027-5033 (Pubitemid 32280715)